| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 55 |
| 1 | ADALIMUMAB-AATY | 55 |
| 2 | ADALIMUMAB-ADAZ | 55 |
| 3 | ADALIMUMAB-FKJP | 55 |
| 4 | PEMBROLIZUMAB | 42 |
| 5 | METHOTREXATE | 33 |
| 6 | METHOTREXATE SODIUM | 33 |
| 7 | NIVOLUMAB | 32 |
| 8 | TRASTUZUMAB | 28 |
| 9 | PACLITAXEL | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 1 | ADALIMUMAB-FKJP | 55 | 0.0012 |
| 2 | ADALIMUMAB-AATY | 55 | 0.0011 |
| 3 | ADALIMUMAB-ADAZ | 55 | 0.0010 |
| 4 | AVELUMAB | 4 | 0.0010 |
| 5 | PERTUZUMAB | 24 | 0.0009 |
| 6 | HYALURONATE SODIUM | 1 | 0.0007 |
| 7 | DABRAFENIB | 13 | 0.0006 |
| 8 | ROPEGINTERFERON ALFA-2B | 1 | 0.0005 |
| 9 | TRAMETINIB | 12 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 72 | 0.0007 |
| 2 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 28 | 0.0004 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 7 | 0.0003 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 13 | 0.0003 |
| 6 | Microtubule Inhibitor [EPC] | 40 | 0.0002 |
| 7 | Antiparasitic [EPC] | 1 | 0.0002 |
| 8 | Pediculicide [EPC] | 1 | 0.0002 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |